IP Verse

Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods Thereof - EP3229799

The patent EP3229799 was granted to Crystal Pharmatech on Oct 17, 2018. The application was originally filed on Dec 8, 2015 under application number EP15843405A. The patent is currently recorded with a legal status of "Revoked".

EP3229799

CRYSTAL PHARMATECH
Application Number
EP15843405A
Filing Date
Dec 8, 2015
Status
Revoked
Dec 9, 2024
Grant Date
Oct 17, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

D YOUNGJul 17, 2019D YOUNG -

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2009061713
INTERNATIONAL-SEARCH-REPORTUS2014329872
INTERNATIONAL-SEARCH-REPORTUS8877938
OPPOSITIONCN105037289
OPPOSITIONWO2007056546
OPPOSITIONWO2016049663
OPPOSITIONWO2016201238

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents